RNA viruses are responsible for numerous human diseases; some of these viruses are also potential agents of bioterrorism. In general, the replication of RNA viruses results in the incorporation of at least one mutation per round of replication, leading to a heterogeneous population, termed a qua-sispecies. The antiviral nucleoside ribavirin has been shown to cause an increase in the mutation frequency of RNA viruses. This increase in mutation frequency leads to a loss of viability due to error catastrophe. In this article, we review lethal mutagenesis as an antiviral strategy, emphasizing the challenges remaining for the development of lethal mutagenesis into a practical clinical approach.
AiraksinenAParienteNMenendez-AriasL & DomingoE (2003) Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology311: 339–349.
2.
AndersonEP (1973) Nucleoside and nucleotide kinases. In The Enzymes. Edited by BoyerPD. New York: Academic Press, vol. 9, pp 49–96.
3.
AndreiG & De ClercqE (1993) Molecular approaches for the treatment of hemorrhagic fever virus infections. Antiviral Research22: 45–75.
4.
BalteraRFJr & TershakDR (1989) Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C. Journal of Virology63: 4441–4444.
5.
BassBL (2002) RNA editing by adenosine deaminases that act on RNA. Annual Review of Biochemistry71: 817–846
6.
BoothCMMatukasLMTomlinsonGARachlisARRoseDBDwoshHAWalmsleySLMazzulliTAvendanoMDerkachPEphtimiosIEKitaiIMederskiBDShadowitzSBGoldWLHawryluckLAReaEChenkinJSCesconDWPoutanenSM & DetskyAS (2003). Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA: The Journal of the American Medical Association289: 2801–2809.
7.
BourdaisJBiondiRSarfatiSGuerreiroCLascuIJaninJ & VeronM (1996) Cellular phosphorylation of anti-HIV nucleosides. Role of nucleoside diphosphate kinase. Journal of Biological Chemistry271: 7887–7890.
8.
BradburyNA & BridgesR.J. (1994) Role of membrane trafficking in plasma membrane solute transport. American Journal of Physiology267: C1–C24.
9.
CabritaMABaldwinSAYoungJD & CassCE (2002) Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes. Biochemistry & Cell Biology80: 623–638.
10.
CameronCE & CastroC (2001) The mechanism of action of ribavirin: Lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. Current Opinion in Infectious Diseases14: 757–764.
11.
CarrollSSTomassiniJEBossermanMGettyKStahlhutMWEldrupABBhatBHallDSimcoeALLaFeminaRRutkowskiCAWolanskiBYangZMigliaccioGDe FrancescoRKuoLCMacCossM & OlsenDB (2003) Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs. Journal of Biological Chemistry278: 11979–11984.
12.
CassCEYoungJDBaldwinSACabritaMAGrahamKAGriffithsMJenningsLLMacKeyJRNgAMLRitzelMWLVickersMF & YaoSYM (1999) Nucleoside transporters of mammalian cells. In Membrane Transporters as Drug Targets (AmidonG. L., and SadeeW., Eds.), pp 313–352. Kluwer Academic/Plenum Publishers, New York.
13.
CattaneoR (1994) Biased (A–>I) hypermutation of animal RNA virus genomes. Current Opinion in Genetics & Development4: 895–900.
14.
ContrerasAMHiasaYHeWTerellaASchmidtEV & ChungRT (2002) Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. Journal of Virology76: 8505–8517.
15.
CrottySCameronCE & AndinoR (2001) RNA virus error catastrophe: Direct molecular test by using ribavirin. Proceedings of the National Academy of Sciences, USA98: 6895–900.
16.
CrottySMaagDArnoldJJZhongWLauJYHongZAndinoR & CameronCE (2000) The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nature Medicine6: 1375–1379.
17.
CummingsKJLeeSMWesESCid-RuzafaJFeinSGAokiYSulkowskiMS & GoodmanSN (2001) Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials. JAMA: The Journal of the American Medical Association285: 193–199.
18.
DavisGLEsteban-MurRRustgiVHoefsJGordonSCTrepoCShiffmanMLZeuzemSCraxiALingMH & AlbrechtJ (1998) Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. New England Journal of Medicine339: 1493–1499.
19.
De ClercqE (1993) Antiviral agents: Characteristic activity spectrum depending on the molecular target with which they interact. Advances in Virus Research42: 1–55.
20.
DomingoEEscarmisCSevillaNMoyaAElenaSFQuerJNovellaIS & HollandJJ (1996) Basic concepts in RNA virus evolution. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 10: 859–864.
21.
DrakeJW & HollandJJ (1999) Mutation rates among RNA viruses. Proceedings of the National Academy of Sciences, USA96: 13910–13910.
22.
ErikssonBHelgstrandEJohanssonNGLarssonAMisiornyANorenJOPhilipsonLStenbergKSteningGStridhS & ObergB (1977) Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrobial Agents & Chemotherapy11: 946–951.
23.
Gallois-MontbrunSSchneiderBChenYGiacomoni-FernandesVMulardLMoreraSJaninJDeville-BonneD & VeronM (2002) Improving nucleoside diphosphate kinase for antiviral nucleotide analogs activation. Journal of Biological Chemistry277: 39953–39959.
24.
GatiWPMisraHKKnausEE & WiebeLI (1984) Structural modifications at the 2′- and 3′-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter. Biochemical Pharmacology. 33: 3325–3331.
25.
GourdeauHClarkeMLOuelletFMowlesDSelnerMRichardALeeNMacKeyJRYoungJDJolivetJLafreniereRG & CassCE (2001) Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines. Cancer Research61: 7217–7224.
26.
GriffithDA & JarvisSM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochimica et Biophysica Acta1286: 153–181.
27.
GriffithsMBeaumontNYaoSYSundaramMBoumahCEDaviesAKwongFYCoeICassCEYoungJD & BaldwinSA (1997) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nature Medicine3: 89–93.
28.
HarkiDAGraciJDKorneevaVSGhoshSKHongZCameronCE & PetersonBR (2002) Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-beta-D-Ribofuranosyl-3-nitropyrrole. Biochemistry41: 9026–9033.
29.
HarrisRSBishopKNSheehyAMCraigHMPetersen-MahrtSKWattINNeubergerMS & MalimMH (2003) DNA deamination mediates innate immunity to retroviral infection. Cell113: 803–809.
30.
HarrisRSPetersen-MahrtSK & NeubergerMS (2002) RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Molecular Cell10: 1247–1253.
31.
HillFLoakesD & BrownDM (1998) Polymerase recognition of synthetic oligodeoxyribonucleotides incorporating degenerate pyrimidine and purine bases. Proceedings of the National Academy of Sciences, USA95: 4258–4263.
32.
HollandJJDomingoEde la TorreJC & SteihauerDA (1990) Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. Journal of Virology64: 3960–3962.
33.
HuM (1993) Comparison of uptake characteristics of thymidine and zidovudine in a human intestinal epithelial model system. Journal of Pharmaceutical Sciences82: 829–833.
34.
HuangQQYaoSYRitzelMWPatersonARCassCE & YoungJD (1994) Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. Journal of Biological Chemistry269: 1757–1760.
35.
HugginsJW (1989) Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Review of Infectious Diseases11: S750–S761.
36.
KochharDMPennerJD & KnudsenTB (1980) Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice. To xicology & Applied Pharmacology52: 99–112.
37.
KrilovLR (2001) Respiratory syncytial virus: Update on infection, treatment, and prevention. Current Infectious Disease Reports3: 242–246.
38.
LanfordREChavezDGuerraBLauJYHongZBraskyKM & BeamesB (2001) Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes. Journal of Virology75: 8074–8081.
39.
LoakesD (2001). Survey and summary: The applications of universal DNA base analogues. Nucleic Acids Research29: 2437–2447.
40.
LoebLAEssigmannJMKazaziFZhangJRoseKD & MullinsJI (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proceedings of the National Academy of Sciences, USA96: 1492–1497.
41.
LoebLA & MullinsJI (2000) Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Research & Human Retroviruses16: 1–3.
42.
LoewenSKNgAMYaoSYCassCEBaldwinSA & YoungJD (1999) Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2. Journal of Biological Chemistry274: 24475–24484.
43.
MaagDCastroCHongZ & CameronCE (2001) Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. Journal of Biological Chemistry276: 46094–46098.
44.
MigliaccioGTomassiniJECarrollSSTomeiLAltamuraSBhatBBatholomewLBossermanMRCeccacciAColwellLFCorteseRDe FrancescoREldrupABGettyKLHouXSLaFeminaRLLudmererSWMacCossMMcMastersDRStahlhutMWOlsenDBHazudaDJ & FloresOA (2003) Characterization of resistance to non-obligate chain terminating ribonucleoside analogs which inhibit HCV replication in vitro. Journal of Biological Chemistry278: 49164–49170.
45.
MillerJPKigwanaLJStreeterDGRobinsRKSimonLN & RobozJ (1977) The relationship between the metabolism of ribavirin and its proposed mechanism of action. Annals of the New York Academy of Sciences284: 211–229.
46.
MoriyamaKNegishiKBriggsMSSmithCLHillFChurcherMJBrownDM & LoakesD (1998) Synthesis and RNA polymerase incorporation of the degenerate ribonucleotide analogue rPTP. Nucleic Acids Research26: 2105–2111.
47.
MoriyamaKOtsukaCLoakesD & NegishiK (2001) Highly efficient random mutagenesis in transcription-reverse-transcription cycles by a hydrogen bond ambivalent nucleoside 5′-triphosphate analogue: Potential candidates for a selective anti-retroviral therapy. Nucleosides, Nucleotides & Nucleic Acids20: 1473–1483.
48.
NegishiKWilliamsDMInoueYMoriyamaKBrownDM & HayatsuH (1997) The mechanism of mutation induction by a hydrogen bond ambivalent, bicyclic N4-oxy-2′-deoxycytidine in Escherichia coli. Nucleic Acids Research25: 1548–1552.
49.
NicholsRAndrewsPCZhangP & BergstromDE (1994) A universal nucleoside for use at ambiguous sites in DNA primers. Nature369: 492–493.
50.
PageT & ConnorJD (1990) The metabolism of ribavirin in erythrocytes and nucleated cells. International Journal of Biochemistry22: 379–383.
51.
ParienteNSierraSLowensteinPR & DomingoE (2001) Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. Journal of Virology75: 9723–2730.
52.
PfeifferJK & KirkegaardK (2003) A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proceedings of the National Academy of Sciences, USA100: 7289–7294.
53.
PolsonAGBassBL & CaseyJL (1996) RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature380: 454–456.
54.
RtizelMWNgAMYaoSYGrahamKLoewenSKSmithKMHydeRJKarpinskiECassCEBaldwinSA & YoungJD (2001a) Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: Identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). Molecular Membrane Biology18: 65–72.
55.
RitzelMWNgAMYaoSYGrahamKLoewenSKSmithKMRitzelRGMowlesDACarpenterPChenXZKarpinskiEHydeRJBaldwinSACassCE & YoungJD (2001b) Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). Journal of Biological Chemistry276: 2914–2927.
56.
RitzelMWYaoSYHuangMYElliottJFCassCE & YoungJD (1997) Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). American Journal of Physiology272: C707–C714.
57.
RitzelMWYaoSYNgAMMacKeyJRCassCE & YoungJD (1998) Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Molecular Membrane Biology15: 203–211.
58.
RossJ (1996) Control of messenger RNA stability in higher eukaryotes. Trends in Genetics12: 171–175.
59.
Ruiz-JaraboCMLyCDomingoE & de la TorreJC (2003) Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology308: 37–47.
60.
ScheidelLM & StollarV (1991) Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the non-structural protein nsP1. Virology181: 490–499.
61.
SchneiderBXuYWSellamOSarfatiRJaninJVeronM & Deville-BonneD (1998) Pre-steady state of reaction of nucleoside diphosphate kinase with anti-HIV nucleotides. Journal of Biological Chemistry273: 11491–11497.
62.
SeversonWESchmaljohnCSJavadianA & JonssonCB (2003) Ribavirin causes error catastrophe during Hantaan virus replication. Journal of Virology77: 481–488.
63.
SheehyAMGaddisNCChoiJD & MalimMH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature418: 646–650.
SintchakMD & NimmesgernE (2000) The structure of inosine 5′-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology47: 163–184.
66.
SmardonASpoerkeJMStaceySCKleinMEMacKinN & MaineEM (2000) EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C. elegans Current Biology10: 169–178.
67.
SteinhauerDADomingoE & HollandJJ (1992) Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene122: 281–288.
68.
StreeterDGWitkowskiJTKhareGPSidwellRWBauerRJRobinsRK & SimonLN (1973) Mechanism of action of 1-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proceedings of the National Academy of Sciences, USA70: 1174–1178.
69.
TamRCRamasamyKBardJPaiBLimC & AverettDR (2000) The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels. Antimicrobial Agents & Chemotherapy44: 1276–1283.
70.
TrautTW (1994) Physiological concentrations of purines and pyrimidines. Molecular & Cellular Biochemistry140: 1–22.
71.
Van RompayARJohanssonM & KarlssonA (2000) Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacology & Therapeutics87: 189–198.
72.
WagnerCRIyerVV & McInteeEJ (2000) Pronucleotides: Toward the in vivo delivery of antiviral and anticancer nucleotides. Med Res Rev20: 417–451.
73.
WiannyF & Zernicka-GoetzM (2000). Specific interference with gene function by double-stranded RNA in early mouse development. Nature Cell Biology2: 70–75.
74.
WongSKSatoS & LazinskiDW (2003) Elevated activity of the large form of ADAR1 in vivo: Very efficient RNA editing occurs in the cytoplasm. RNA9: 586–598.
75.
WraySKGilbertBENoallMW & KnightV (1985) Mode of action of ribavirin: Effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. Antiviral Research5: 29–37.
76.
YaoSYNgAMMuzykaWRGriffithsMCassCEBaldwinSA & YoungJD (1997) Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. Journal of Biological Chemistry272: 28423–28430.
77.
YoungKCLindsayKLLeeKJLiuWCHeJWMilsteinSL & LaiMM (2003) Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. Hepatology38: 869–78.
78.
YuHEritjaRBloomLB & GoodmanMF (1993) Ionization of bromouracil and fluorouracil stimulates base mispairing frequencies with guanine. Journal of Biological Chemistry268: 15935–15943.
79.
ZhouSLiuRBaroudyBMMalcolmBA & ReyesGR (2003) The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. Virology310: 333–342.
80.
ZimmermanTP & DeeproseRD (1978) Metabolism of 5-amino-1-beta-D-ribofuranosylimidazole-4-carboxamide and related five-membered heterocycles to 5′-triphosphates in human blood and L5178Y cells. Biochemical Pharmacology27: 709–716.
81.
ZimmermanTPMahonyWB & PrusKL (1987) 3′-azido-3′-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion. Journal of Biological Chemistry262: 5748–5754.
